History

La Jolla Institute for Allergy & Immunology was established in 1988 by a coalition of leaders from academia and industry, including Dr. Makoto Nonaka, the Institute's founding President, and Dr. Kimishige Ishizaka, the Institute's first Scientific Director. These leaders envisioned a unique and dynamic partnership between basic science and applied research, one that would lead to breakthroughs in the understanding of the immune system and improve human health through the development of treatments and cures for immune system disorders.

UCSD AND THE SCRIPPS RESEARCH INSTITUTE
The La Jolla Institute was formed with strong ties to major academic and medical centers, including the University of California, San Diego (UCSD) and The Scripps Research Institute. LIAI's first Board of Directors included Dr. Gerard Burrow, past Dean of UCSD's School of Medicine. Dr. Burrow developed an affiliation between LIAI and UCSD Medical Center that provides for joint research activities, consultation and training in the fields of allergy and immunology. Peter Preuss, LIAI's founding Chairman, also has strong ties to UCSD and currently serves on the University of California's Board of Regents. Dr. Frank Dixon, who was recruited to The Scripps Research Institute in 1961 and became its first director, was a founding board member of LIAI and served as Chairman of the Institute's Board of Directors for 14 out of his 16 years on the board.

TIMELINE
1989 - Beginning Laboratory Operations
The Institute began its laboratory operations in 1989 with the arrival of two pioneering immunologists, Dr. Kimishige Ishizaka and Dr. Teruko Ishizaka, from Johns Hopkins University in Baltimore, Maryland. The Ishizaka's received worldwide recognition in 1966 for their discovery of the IgE (immunoglobulin E) protein, a molecule that induces allergic reactions in the human body.

1991 - Dr. Kimishige Ishizaka appointed President/Scientific Director of the Institute
In 1991 Dr. Kimishige Ishizaka was appointed President/Scientific Director of the Institute and served in this role until his retirement in 1995. Under Dr. Ishizaka's leadership, LIAI quickly established a worldwide reputation for excellence in allergy and immunology research.

1995 to 2003 - Dr. Howard Grey leads the Institute
Dr. Howard Grey joined LIAI in 1995, succeeding Dr. Ishizaka as President/Scientific Director of the Institute. The following year, LIAI moved from its initial location on Torrey Pines Road in La Jolla to a newly designed and constructed facility on Science Center Drive on the Torrey Pines Mesa. During the next several years, Dr. Grey led the Institute through a period of growth that included the recruitment of prominent faculty members and the formation of a program to accelerate the commercial development of LIAI's research and drug discovery plans. During Dr. Grey's tenure the Institute more than doubled in size, achieved significant scientific advances, and further established itself as a leader in immunologic research.

2003 to Present - Expansion and new State of the Art Research Facility
Since its inception, LIAI has benefited from strong leadership. Today, the Institute is led by Dr. Mitchell Kronenberg, who was appointed as President/Scientific Director in 2003, now serves as President and Chief Scientific Officer. Dr. Kronenberg's vision for the future has included the development of a new research facility to accommodate the Institute's growth, an accompanying expansion of LIAI faculty and laboratories, the creation of an Emerging Infectious Disease and Biodefense Center at LIAI, and the development of a joint Center for Immunology with UCSD.

When Drs. Kimi and Terry Ishizaka helped found the Institute in the 1980's, they created a standard of scientific excellence, as well as an environment where warmth and respect existed among colleagues. That legacy continues at LIAI to this day, and it fosters a highly innovative and collaborative research environment in which the Institute takes great pride.

LIAI was recently ranked among the top five molecular biology and genetics research institutions in the world. The Institute currently has over 200 employees, more than half who have doctoral (Ph.D. or M.D.) degrees.

 

Founding Director
Dr. Kimishige Ishizaka served in the dual role of President and Scientific Director of LIAI until his retirement in 1996. He is currently President Emeritus of LIAI and also on the LIAI Board of Directors as a Director Emeritus.

Read "My Resume" by Dr. Kimi Ishizaka translated by Katsuji Sugie, M.D., Ph.D., (DI-1a) from the Japanese newspaper "Nihon Keizai Shinbun."
how to help
news
  • 1/23/2012 - La Jolla Institute Scientist Takes Quest to Conquer Type 1 Diabetes to the Next Level
    Learn More
  • 1/12/2012 - La Jolla Institute Researchers Identify Pivotal Immune Cell in Type 1 Diabetes in Humans
    Learn More
  • 12/24/2011 -  San Diego Union-Tribune Top 5 San Diego Science Stories of 2011 | La Jolla Institute Highlighted in Stem Cell Central
    Article link | .pdf
upcoming seminars
  • Maki Nakayama, "Insulin TcR transgenic mice and TcR and diabetes penetrance" Wednesday 08/17/11: 12:00 PM
  • Casey Weaver, "Sequential Actions of Innate and Adaptive Immune Cells in Intestinal Antibacterial Defense: A Shared Role for IL-22" Thursday 08/25/11: 12:00 PM
  • More Seminars